Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 335 in its research report dated May 29, 2023.

Buy Aster DM Healthcare; target of Rs 335: Prabhudas Lilladher

Aster’s PAT for FY23 dropped by 19 per cent to ₹425 crore from ₹526 crore in FY22

Aster DM Healthcare’s Q4 PAT drops 24% to ₹171 crore

The fall in Aster DM’s bottomline was largely due to the launch of five new hospitals across in Gulf Cooperation Council states and India

Aster DM Healthcare slumps 6% as Q4 net profit declines 24.5%

Global healthcare provider, Aster DM Healthcare on Thursday announced the launch of its Telecommand Centre and Digital Health, India office in Bengaluru.

Aster DM opens telecommand centre and digital health facility in Bengaluru

Buzzing stocks: Vedanta, NHPC, Jindal Stainless, Apollo Tyres, PNB Housing, Cholamandalam Investment, DCB Bank, Aster DM Healthcare, RPP Infra, Dev Information, Somany Ceramics, Zydus Life, GR Infraprojects

Stocks that will see action on March 29, 2023

The deal values Aster DM Healthcare at $1.4 billion, the company said.

Promoters Increase Stake In Aster DM Healthcare By 4% For Rs 460 Crore

The hospital chain operates 15 hospitals offering 4,095 beds, which will go up to 4,670 across 18 hospitals by the next financial year and is the largest chain in the GCC countries with 15 hospitals. They also operate 113 clinics and 257 pharmacies in these Gulf Cooperation Council markets

Promoters increase stake in Aster DM Healthcare by 4% for Rs 460 cr

With the latest share purchase, the promoters of Aster DM Healthcare have increased their shareholding in the India-listed company to 41.88%

Aster DM promoter family increases stake by 4%

The promoters of Aster DM Healthcare have increased their shareholding by 4 per cent, from 37.88 per cent to 41.88 per cent, with for an investment of ₹460 crore

Aster DM Healthcare’s promoters increase stake by 4% for ₹460 cr

Today’s Pick: Aster DM Healthcare (₹238.40): BUY

“Aster DM Healthcare has been in a strong uptrend since 2020 and has recently bounced back from its 89-EMA on the weekly charts,” Gaurav Bissa, VP, InCred Equities, said.

#stockmarket #stocks #stockrecommendation #stockstobuy #stockmarketnews 

► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes 
► Twitter - https://www.twitter.com/economictimes
► LinkedIn - https://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews

Stock Radar: Aster DM Healthcare buy for a target of Rs 250, says Gaurav Bissa

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aster DM Healthcare Limited is a healthcare service provider. The Company operates in various segments of the healthcare industry, which include hospitals, clinics and retail pharmacies